Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid-derived suppressor cells with a selective inhibitor of PI3Kd/g

Ruth J. Davis, Ellen C. Moore, Paul E. Clavijo, Jay Friedman, Harrison Cash, Zhong Chen, Chris Silvin, Carter Van Waes, Clint T Allen

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid-derived suppressor cells with a selective inhibitor of PI3Kd/g'. Together they form a unique fingerprint.

Medicine & Life Sciences